DNA gyrase-inhibitory antimicrobial anthraquinone from the endophytic Sordariomycetes fungus Diaporthe perseae
- 28 August 2025
- journal article
- research article
- Published by Springer Nature in Archives of Microbiology
- Vol. 207 (10) , 1-19
Abstract
Fungi of the order Diaporthales are prolific sources of antimicrobial secondary metabolites. In this paper, we describe antimicrobial and antituberculosis anthraquinones (AQs) from Diaporthe perseae, an endophytic fungus isolated and identified from the endemic Philippine medicinal plant Uvaria alba (Annonaceae). Large-scale rice fermentation of D. perseae yielded an ethyl acetate extract which was subjected to a series of chromatographic purification to yield three compounds. Spectroscopic analyses allowed the identification of the anthraquinone compounds citreorosein (1), skyrin (2), and rugulosin A (3). AQs 1 and 3 showed broad-spectrum against Gram-positive bacteria (Micrococcus luteus, Bacillus subtilis, and Staphylococcus aureus) (MIC = 1.0–2.0 µg/mL), however only 3 demonstrated strong inhibition against Gram-negative bacterial strains (Escherichia coli, Pseudomonas aeruginosa, and Chromobacterium violaceum) and non-TB mycobacteria (Mycobacterium smegmatis) (MIC = 8.25–66.0 µg/mL). AQ 3 also exhibited inhibition against both M. tuberculosis (Mtb) H37Rv (Microplate Alamar Blue Assay; MABA MIC = 29.2 µg/mL) and its non-replicating persistent strain (Low-Oxygen Recovery Assay; LORA MIC = 30.3 µg/mL). To explore the potential mechanism of 3, DNA supercoiling assay was performed. Thus, rugulosin A (3) displayed inhibition of Mtb. DNA gyrase, an enzyme necessary for genomic replication via ATP-dependent DNA relaxation mechanisms. Molecular docking and molecular dynamics revealed strong, stable binding affinity of 3 (BE = -9.5 kcal/mol) and its tautomer 4 (BE = -9.6 kcal/mol) within the active pocket of the MtbDNA gyrase. Overall, rugulosin A (3) represents a promising antibiotic prototype with in vitro and in silico activity against M. tuberculosis, and identifies DNA gyrase as therapeutic target for anthraquinone antimycobacterials.Keywords
Funding Information
- DOST Grants-in-Aide-National Research Council of the Philippines.
- Digital Cooperation and Large Equipment Grants by the Alexander von Humboldt Foundation
This publication has 82 references indexed in Scilit:
- Recent Advances in the Synthesis of DiarylheptanoidsChemistry – An Asian Journal, 2024
- Computationally Repurposed Natural Products Targeting SARS-CoV-2 Attachment and Entry Mechanisms2022
- Nanotechnology‐Based Targeted Drug Delivery: An Emerging Tool to Overcome TuberculosisAdvanced Therapeutics, 2020
- Three‐Component Synthesis of Tetrazolo Anthraquinone as a Representation of a New Heterocyclic SystemChemistrySelect, 2019
- Natural Products from Diaporthe arecae with Anti‐Angiogenic ActivityIsrael Journal of Chemistry, 2019
- Antibacterial and Antioxidant Metabolites of Diaporthe spp. Isolated from Flowers of Melodorum fruticosumCurrent Microbiology, 2017
- Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approachIntensive Care Medicine, 2017
- 3-Hydroxypropionic Acid as an Antibacterial Agent from Endophytic Fungi Diaporthe phaseolorumCurrent Microbiology, 2012
- Endophytic fungi: novel sources of anticancer lead moleculesApplied Microbiology and Biotechnology, 2012
- Carbon‐13 NMR spectroscopy of the biological pigments luteoskyrin and rugulosin and some polyhydroxyanthraquinone analoguesMagnetic Resonance in Chemistry, 1975